Synucleinopathy is a group of brain disorders that slowly affect movement, thinking, sleep, and the automatic body functions that control things like blood pressure and bladder function. The early symptoms of synucleinopathy can look different from one person to another, but may include tremor, stiffness, slowed movement, constipation, acting out dreams during sleep, fainting, or changes in memory and attention. It usually develops in adults, often later in life, and it tends to progress over years, though the pace can vary. Not everyone will have the same experience. Treatment does not cure synucleinopathy, but medicines, physical therapy, exercise, and support for sleep, mood, blood pressure, and thinking problems can help, and serious forms can shorten life expectancy.

How many people live with Synucleinopathy?

Because synucleinopathy is an umbrella term for conditions such as Parkinson's disease and Lewy body dementia, there is no single official head count, but a reasonable estimate is about 11-14 million people worldwide (WHO, 2022; WHO, 2023; Lewy Body Dementia Association, 2024), based mainly on more than 8.5 million people living with Parkinson's disease and Lewy body dementia making up about 5-10% of the 55 million people living with dementia. In the United States, a similar rough estimate is about 2.4 million people (Parkinson's Foundation, 2022; Lewy Body Dementia Association, 2024), not a direct count, because this group also includes rarer related disorders.

Overview

Synucleinopathy

Symptoms

Synucleinopathy often causes slow changes in movement, thinking, sleep, and mood. People may notice tremor, stiffness, balance problems, constipation, vivid dreams, or seeing things that are not there.

Outlook and prognosis

Synucleinopathy usually changes over time, but the pace can vary widely. Many living with synucleinopathy need more support with movement, sleep, mood, or thinking as symptoms build. Treatment often helps ease symptoms and protect daily function for years.

Causes and risk factors

The exact cause of synucleinopathy is often unclear. Risk rises with aging, certain gene changes, and sometimes family history. Pesticide exposure, repeated head injury, and other biological and environmental factors may add to risk, while lifestyle factors are less clearly linked.

Genetic influences

Genetics can matter in synucleinopathy, but most cases are not caused by a single inherited change. In some families, rare gene variants raise risk or affect when symptoms start, while common genetic differences may slightly influence susceptibility.

Diagnosis

Diagnosing synucleinopathy is based on symptoms, a neurologic exam, and brain imaging to rule out other causes. Doctors may also use sleep studies, smell testing, or specialized scans; a definite diagnosis sometimes requires tissue findings after death.

Treatment and drugs

Treatment for synucleinopathy focuses on easing day-to-day symptoms. Medicines may help movement, sleep, mood, blood pressure, or hallucinations, depending on the type. Physical therapy, speech therapy, and regular follow-up can also support safety and independence.

Symptoms

Synucleinopathy can show up in daily life as a mix of movement, sleep, body-function, and thinking changes. Some people first notice constipation, acting out dreams, a softer voice, reduced sense of smell, or a new tremor, while others develop dizziness on standing or slowed thinking. Symptoms vary from person to person and can change over time. Because the early symptoms of synucleinopathy can overlap with other conditions, it may take time and testing to sort out the cause.

Slow stiff movement

Movements can become slower and smaller, and muscles may feel tight or rigid. Many living with synucleinopathy notice that buttoning clothes, getting out of a chair, or turning in bed takes more effort.

Tremor

A shaking movement, often in one hand at rest, can happen but is not present in everyone. Stress, fatigue, or sitting quietly may make it easier to notice.

Balance walking changes

Walking may become shuffling or unsteady, with less arm swing and trouble turning. Some people have freezing, where the feet briefly feel stuck to the floor, which can lead to near falls or falls.

Sleep problems

Sleep may become broken, and some people talk, shout, punch, or kick while dreaming. Daytime sleepiness can also build up, making it harder to stay alert during quiet activities.

How people usually first notice Synucleinopathy?

Synucleinopathy is usually first noticed not as a lab finding, but as small changes that start to interrupt everyday life: a tremor, stiffness, moving more slowly, acting out dreams during sleep, constipation, or a fading sense of smell. Because synucleinopathies include conditions such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, the first signs of synucleinopathy can differ from one person to another, and in some people memory changes, visual hallucinations, dizziness when standing, or balance problems show up early instead of tremor. Many living with a synucleinopathy are first diagnosed only after these subtle symptoms begin to cluster over time, which is why new movement, sleep, thinking, or autonomic symptoms are worth discussing with a clinician.

Dr. Wallerstorfer Dr. Wallerstorfer

Types of Synucleinopathy

Synucleinopathy is an umbrella term for a group of brain and nerve disorders linked to buildup of a protein called α-synuclein. The main types of synucleinopathy share some features, but they differ in which problems show up first and which parts of daily life are affected most. One person might struggle mostly with movement, while another notices more changes in memory, blood pressure, or balance.

Parkinson's disease

This type usually starts with movement symptoms such as tremor, slowness, stiffness, or a smaller, softer way of moving through the day. Many living with Parkinson's disease also develop non-movement symptoms like constipation, sleep changes, reduced sense of smell, or low mood. Thinking and memory problems can happen later, but they are not usually the first main feature.

Lewy body dementia

In this type, changes in thinking, attention, or visual hallucinations often appear early, sometimes around the same time as movement symptoms. People with Lewy body dementia may seem quite alert one hour and much more confused the next, and balance, sleep, and blood pressure problems are also common. Symptoms don't always look the same for everyone.

Multiple system atrophy

This form often causes a mix of movement problems and strong autonomic symptoms, which affect automatic body functions like blood pressure, bladder control, sweating, and sexual function. Some people mainly have Parkinson-like slowness and stiffness, while others have more trouble with coordination, walking, and speech. Compared with other variants of synucleinopathy, progression is often faster.

Pure autonomic failure

This type mainly affects the autonomic nervous system rather than causing early major movement or memory problems. People may notice dizziness on standing, fainting, trouble regulating body temperature, bladder issues, or constipation that interferes with everyday routines. In some cases, pure autonomic failure stays limited, while in others it can later overlap with another synucleinopathy.

Can I slow down the onset of symptoms?

Not in a proven way: right now, there is no treatment or lifestyle change that has been shown to reliably delay the start of symptoms in synucleinopathy, though research suggests that regular exercise, good sleep, staying mentally and socially active, and keeping blood pressure, blood sugar, and cholesterol in a healthy range may help lower risk or support brain health. These steps may improve overall brain and body health, but they are not known to prevent synucleinopathy, and the evidence for delaying onset is still limited. There is no established preventive medicine for people without symptoms, but regular check-ins with a doctor can help spot changes early and support the best care possible.

What genetics can tell you about symptoms

Genetics can sometimes give clues about symptoms in synucleinopathy, but it usually cannot predict exactly how the condition will look in one person. Changes in certain genes linked to α-synuclein and related pathways may affect whether symptoms start earlier or later, how quickly they worsen, and whether movement, thinking, sleep, or automatic body functions are more affected. Even so, symptoms vary widely, and day-to-day features are shaped by more than genes alone.

Dr. Wallerstorfer Dr. Wallerstorfer

Causes and risk factors

Synucleinopathy usually develops from a mix of aging, genes, and changes inside brain cells. In some people, inherited gene changes affect a brain protein called α-synuclein or the systems that clear damaged proteins. Older age, male sex, and long-term exposure to certain pesticides or solvents are among the better known risk factors for synucleinopathy. Not everyone with the same risk develops the condition. Lifestyle factors such as low physical activity and poor cardiovascular health may also influence risk, but they do not explain most cases.

What are the most common causes or risk factors?

Synucleinopathy is a group of brain conditions linked to a buildup of a protein called α-synuclein, but in most people the exact cause of that buildup is not clear. The strongest risk factor is older age, and risk can also be higher if close family members have had Parkinson's disease, Lewy body dementia, or a related condition, sometimes because of inherited gene changes. Long-term exposure to certain pesticides or industrial chemicals and, in some people, repeated head injuries may also raise the risk.

Environmental and biological risk factors

Synucleinopathy becomes more likely with a mix of body-based factors and outside exposures, although no single factor guarantees that it will happen. Doctors often group risks into internal (biological) and external (environmental). The best-studied biological and environmental risk factors for synucleinopathy are older age, certain sleep-related warning signs, head injury, and repeated exposure to some chemicals or polluted air, with the strongest evidence coming from Parkinson disease and Lewy body disorders.

Older age

Risk rises clearly with age, especially after about 60 years. As the brain gets older, nerve cells are less able to handle protein buildup and other everyday stresses.

REM sleep disorder

Acting out dreams during sleep, called REM sleep behavior disorder, is one of the strongest body-based predictors of later synucleinopathy. It is usually an early warning sign rather than a cause, but it greatly increases the chance that a synucleinopathy is already beginning.

Male sex

Many forms of synucleinopathy are diagnosed more often in males than in females. The reason is not fully settled, but differences in hormones, immune responses, and brain biology may contribute.

Head injury

A past moderate or severe head injury can raise the chance of developing synucleinopathy later on. Risk may be higher after repeated injuries or injuries that caused loss of consciousness.

Genetic risk factors

For many living with synucleinopathy, genetics can help explain why similar problems show up in several relatives or why disease starts earlier in some families. The strongest inherited links involve genes tied to α-synuclein itself or to the way brain cells break down and recycle proteins, but the pattern can differ between Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Carrying a genetic change doesn’t guarantee the condition will appear.

Gene illustration
  • SNCA changes: Rare changes or extra copies of the SNCA gene are among the clearest inherited causes of synucleinopathy. They can raise risk strongly and may be linked with earlier onset or faster progression. Common SNCA variants can also play a smaller part in genetic risk factors for synucleinopathy.

  • GBA1 variants: Changes in GBA1 are a well-established inherited risk factor for Parkinson disease and dementia with Lewy bodies. They do not mean someone will definitely develop either condition, and people with the same risk factor can have very different experiences. In some families, these variants are linked with earlier symptoms or more thinking and memory changes.

  • LRRK2 variants: Certain LRRK2 variants can raise the chance of Parkinson disease, one major type of synucleinopathy. These variants are uncommon overall but appear more often in some families and ancestry groups. Many people who carry one of these variants never develop symptoms.

  • Family history: Having a close relative with Parkinson disease, dementia with Lewy bodies, or another synucleinopathy can point to shared inherited risk. This does not always mean there is one single gene behind it, because several small genetic influences can add up. Exploring your family’s health background is a valuable starting point.

  • APOE and MAPT: Some genetic risk factors are more closely linked to one subtype than another. APOE is mainly linked with dementia with Lewy bodies, while MAPT has been tied more strongly to Parkinson disease and in some studies to multiple system atrophy. This helps explain why synucleinopathy does not follow one single genetic pattern.

Dr. Wallerstorfer Dr. Wallerstorfer

Lifestyle risk factors

Daily habits can meaningfully affect symptom burden, day-to-day function, and complication risk in synucleinopathy. When people ask about lifestyle risk factors for synucleinopathy, the most relevant issues are physical inactivity, poor sleep, unbalanced eating patterns, alcohol or sedative use, and habits that increase falls or social withdrawal. These factors do not act alone, but they can worsen mobility, cognition, autonomic symptoms, and overall resilience.

Physical inactivity

Too little movement can accelerate loss of strength, balance, gait efficiency, and overall conditioning in synucleinopathy. Regular aerobic, resistance, and balance training may help preserve mobility, reduce falls, and support brain and autonomic function.

Poor sleep

Fragmented sleep, irregular schedules, and untreated sleep problems can worsen fatigue, attention, mood, and daytime function. In synucleinopathy, disturbed sleep may also intensify confusion, hallucinations, and caregiver burden.

Unbalanced diet

Low-fiber, low-fluid, or highly processed eating patterns can aggravate constipation, blood sugar swings, and low energy. A more consistent diet with adequate protein timing, fiber, and hydration may improve bowel function, stamina, and medication tolerance.

Dehydration

Not drinking enough can worsen dizziness, low blood pressure on standing, constipation, and kidney stress. Because autonomic dysfunction is common in synucleinopathy, dehydration can directly increase fainting and fall risk.

Risk prevention

There is no sure way to prevent synucleinopathy, and for many living with it, the main goal is to lower risk where possible and catch problems early. Prevention is about lowering risk, not eliminating it completely. The best-supported steps are the same ones that protect brain and blood vessel health, while also avoiding triggers that may add strain over time.

Stay active

Regular physical activity may help protect brain health and lower the risk of some synucleinopathy disorders, especially Parkinson disease. Aim for steady movement most days, such as walking, cycling, swimming, or strength work that fits your ability.

Protect blood vessels

Keeping blood pressure, blood sugar, and cholesterol in a healthy range supports the brain as well as the heart. For many, this means not smoking, limiting alcohol, and getting routine check-ups.

Prevent head injury

Repeated blows to the head may raise the risk of later brain disease. Seat belts, helmets, fall prevention at home, and safe sports habits can all help reduce that risk.

Limit toxin exposure

Long-term contact with some pesticides, solvents, and other industrial chemicals may be linked with higher risk of synucleinopathy in some studies. Use protective equipment at work and follow safety guidance if you handle these substances.

Can you prevent Synucleinopathy?

Right now, there is no sure way to prevent synucleinopathy, a group of brain conditions that includes Parkinson's disease and Lewy body dementia. Some risks may be lower with general brain-healthy habits like regular physical activity and avoiding repeated head injuries or harmful chemical exposure, but this has not been proven to stop these conditions. For many living with synucleinopathy, it develops for reasons that are still not fully understood, so prevention is only partly possible at best.

Transmission

Synucleinopathy is not infectious, so it does not spread from one person to another through the air, touching, kissing, sex, blood, or everyday caregiving. If you live with someone who has synucleinopathy, sharing meals, hugging them, or helping with personal care will not pass it on to you.

When people ask about how synucleinopathy is inherited, the answer is that most cases are not passed directly from parent to child in a simple way. Some forms within the synucleinopathy group, including a small number of Parkinson's disease cases, can run in families because of inherited gene changes, but for many living with synucleinopathy, the cause is likely a mix of age, biology, and other noninfectious factors.

Gene illustration

When to test your genes

Genetic testing for synucleinopathy is usually most helpful if symptoms begin unusually early, if several relatives have Parkinson disease, dementia with Lewy bodies, or related disorders, or if results could guide family planning or research studies. For many others, routine genetic testing is not yet standard because most cases are not caused by a single inherited gene.

Dr. Wallerstorfer Dr. Wallerstorfer

Diagnosis

For many, the first step comes when everyday activities start feeling harder. Synucleinopathy is usually diagnosed by looking at a pattern of symptoms over time, especially movement changes, sleep behaviors, balance problems, and thinking or mood changes. The diagnosis of synucleinopathy often starts with a careful medical visit and may be supported by brain or nerve-related tests. Some diagnoses are clear after a single visit, while others take more time.

Medical history

Doctors usually begin by asking about symptom changes, when they started, and how they affect daily life. They also ask about sleep problems, fainting, constipation, memory changes, and medicines that could cause similar symptoms.

Neurologic exam

A focused exam checks movement, stiffness, tremor, balance, walking, eye movements, and reflexes. These findings can help show whether the pattern fits a synucleinopathy rather than another brain or nerve condition.

Symptom pattern

The timing and mix of symptoms are a big part of how synucleinopathy is diagnosed. For example, some people first develop Parkinson-like movement symptoms, while others have early memory changes, vivid dream enactment, or prominent blood pressure and bladder problems.

Cognitive testing

Brief memory and thinking tests may be done in the clinic, and some people need more detailed testing. This helps measure attention, planning, visual-spatial skills, and memory, which can be affected in some forms of synucleinopathy.

How is Synucleinopathy diagnosed?

Synucleinopathy is usually diagnosed by looking at the pattern of symptoms over time, taking a careful medical history, and doing a brain and nerve exam, because there is no single simple test that confirms it in most people. Doctors may also use brain scans, memory tests, sleep studies, or tests that check blood pressure, bladder, and other body functions to help tell which type is most likely and to rule out other causes. Genetic testing is not needed for most people, but it may be offered if symptoms start at a younger age or if several family members have had similar problems.

Stages of Synucleinopathy

Synucleinopathy does not have defined progression stages. This is because synucleinopathy is a broad group of brain conditions, and the course can differ a lot depending on the specific disorder and the areas of the nervous system involved. Doctors usually start with a conversation about symptoms such as changes in movement, balance, sleep, blood pressure, memory, or behavior, including the early symptoms of synucleinopathy that may first seem subtle at home. Monitoring often involves repeated neurologic exams over time and, in some cases, brain scans or sleep and autonomic testing to help clarify the pattern.

Outlook and prognosis

Outlook in synucleinopathy varies widely by the specific disorder and how quickly symptoms progress, but most forms are chronic, progressive neurodegenerative illnesses. People with Parkinson disease related to synucleinopathy may live for many years, especially with good symptom management, while those with dementia with Lewy bodies or multiple system atrophy often have faster functional decline. Over time, worsening movement problems, falls, swallowing difficulty, autonomic failure, sleep disturbance, and cognitive impairment can greatly affect independence and quality of life. Mortality is usually related not to the protein abnormality itself but to complications such as aspiration pneumonia, infections, injuries from falls, malnutrition, or severe blood pressure instability. In general, multiple system atrophy carries the poorest prognosis, with average survival often around 6 to 10 years after symptom onset, whereas survival in Parkinson disease is frequently longer and can approach that of the general population in milder cases. Early multidisciplinary care, rehabilitation, treatment of non-motor symptoms, and advance care planning can improve comfort, function, and safety even though no current therapy stops disease progression.

Long-term effects

For many people, synucleinopathy can affect movement, thinking, sleep, and the body functions most of us barely notice until they become harder. The long-term picture is often different from one person to the next, partly because this group of conditions includes illnesses such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Some changes stay mild for years, while others gradually interfere more with walking, work, driving, or independent daily tasks. Thinking about the long-term effects helps set realistic expectations and plan care over time.

Movement changes

Stiffness, slowness, tremor, and balance problems often become more noticeable over time. Many living with synucleinopathy may find that buttoning clothes, getting out of a chair, or turning in bed takes longer and more effort.

Falls and walking

Walking may become shuffling or unsteady, and falls can become a long-term safety issue. This is especially important as balance reflexes weaken and freezing episodes can make the feet feel briefly stuck to the floor.

Thinking and memory

Some people develop trouble with attention, planning, visual processing, or memory as the disease progresses. In some forms, early symptoms of synucleinopathy include subtle confusion, getting lost in familiar places, or trouble judging distances.

Mood and behavior

Depression, anxiety, apathy, and irritability can have a lasting effect on quality of life. Some may also have hallucinations or vivid misperceptions, particularly in forms of synucleinopathy that affect thinking earlier.

How is it to live with Synucleinopathy?

Living with a synucleinopathy often means adapting to symptoms that can shift from day to day, from slowed movement, stiffness, and balance problems to sleep changes, constipation, dizziness, or changes in thinking and mood, depending on the type. For many people, this can affect work, driving, walking safely, and everyday tasks like dressing, eating, or managing medications, but the pattern and pace can vary widely between conditions such as Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. It also touches the people around you, because family and friends may gradually take on more help with planning, transportation, safety, and emotional support, which can be meaningful but also tiring. With the right mix of medical care, therapy, home adjustments, and support, many living with a synucleinopathy can still protect comfort, routine, and connection.

Treatment and drugs

Treatment for synucleinopathy focuses on easing symptoms, maintaining daily function, and supporting quality of life, since there is not yet a cure that removes the underlying protein buildup. Care often depends on the type of synucleinopathy and the symptoms involved, but it may include medicines for movement problems, sleep changes, mood symptoms, dizziness from low blood pressure, or memory and thinking difficulties. Physical, occupational, and speech therapy can also help with walking, balance, swallowing, and communication, which can matter in very practical ways such as getting dressed safely or eating without coughing. Treatment plans often combine several approaches. Because early symptoms of synucleinopathy and later needs can differ a lot from one person to another, regular follow-up helps doctors adjust treatment as the condition changes.

Can you cure Synucleinopathy?

No, there is currently no cure for synucleinopathy, which is a group of brain conditions linked to a harmful buildup of a protein in nerve cells. Treatment can still help by easing symptoms such as movement problems, sleep changes, mood symptoms, or blood pressure drops, and care like medicines, physical therapy, speech therapy, and daily support can improve quality of life. Researchers are studying new treatments, but for now the main goal is to manage symptoms and help people stay as active and comfortable as possible.

Non-drug treatment

Day-to-day life with synucleinopathy can involve movement changes, balance problems, sleep disruption, thinking changes, and shifts in blood pressure or bladder control, so care often works best from several angles at once. Non-drug treatments often lay the foundation for staying safe, mobile, and as independent as possible. The mix of therapies depends on symptoms, since synucleinopathy includes conditions such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Many people use these approaches alongside medication and regular follow-up.

Physical therapy

Physical therapy can help with walking, stiffness, posture, and balance. People with synucleinopathy may practice bigger movements, safer turns, and ways to get up from a chair or out of bed with less risk of falling.

Occupational therapy

Occupational therapy focuses on everyday tasks like dressing, bathing, writing, and using the kitchen safely. Some strategies can slip naturally into your routine—like grab bars, shower seats, better lighting, and simpler home setups that reduce strain and confusion.

Speech therapy

Speech therapy can help if your voice becomes softer, speech less clear, or swallowing more difficult. Structured programs, like voice and swallowing exercises, can help people with synucleinopathy communicate better and lower the risk of choking.

Exercise programs

Regular exercise often supports strength, flexibility, endurance, mood, and bowel function. Walking, cycling, tai chi, yoga, or supervised balance work may also help some of the early symptoms of synucleinopathy, especially slowed movement and unsteadiness.

Your genes may have an impact on how drugs work for you

Small inherited differences in your body can change how you respond to medicines often used for synucleinopathies, including drugs that help movement and some medicines used for mood, sleep, or behavior, so one person may get good symptom relief while another has more nausea, sleepiness, confusion, or low blood pressure. For many living with these conditions, this can mean a dose that works well for a friend or family member may be too much, too little, or cause unwanted effects. This kind of gene-and-medicine matching is called pharmacogenomics, but for synucleinopathies it is not yet a routine part of care and is mainly considered when medication response is unusually hard to predict.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacological treatments

Day-to-day treatment for synucleinopathy usually focuses on easing symptoms such as slowness, stiffness, tremor, sleep problems, blood pressure drops, memory changes, hallucinations, or bladder trouble. The medicines used can differ because synucleinopathy includes conditions such as Parkinson disease, dementia with Lewy bodies, and multiple system atrophy, and each can behave a little differently. Drug treatments are not about fixing everything at once, but about targeting the symptoms that are bothering someone most. Not everyone responds to the same medication in the same way.

Levodopa medicines

Levodopa, usually paired with carbidopa, is the main drug used for slowness, stiffness, and sometimes tremor in many people with synucleinopathy. It often helps movement most in Parkinson disease and may help less in multiple system atrophy or dementia with Lewy bodies.

Dopamine agonists

Pramipexole, ropinirole, and rotigotine can also improve movement symptoms by acting in a similar way to dopamine. They may cause sleepiness, swelling, impulse-control problems, or confusion, so they are often used cautiously, especially in older adults or people with hallucinations.

Movement add-ons

Entacapone, opicapone, and rasagiline are sometimes added when levodopa starts wearing off between doses. Amantadine may help some people with involuntary movements or extra stiffness, although it can sometimes worsen confusion or hallucinations.

Memory medicines

Rivastigmine and donepezil are often used when synucleinopathy affects thinking, attention, or day-to-day function, especially in dementia with Lewy bodies and Parkinson disease dementia. Many people find relief when the right medicine reduces confusion or visual hallucinations as well as memory-related symptoms.

Genetic influences

When similar movement, sleep, or thinking problems show up in more than one relative, many living with synucleinopathy start to wonder about inherited risk. Genetics can play a part in synucleinopathy, but the picture is mixed: most cases are not caused by a single inherited gene, and age and other health or environmental factors also matter. Some gene changes, especially in SNCA, GBA, and LRRK2, can raise the chance of Parkinson's disease or dementia with Lewy bodies, while the genetic contribution to multiple system atrophy is less certain. Family history is one of the strongest clues to a genetic influence. Even so, having a family history of synucleinopathy does not mean someone will definitely develop it, and people without affected relatives can still be diagnosed. If synucleinopathy seems to run in your family or starts unusually early, a genetics specialist or counselor may help explain whether testing could be useful.

Is Synucleinopathy genetic?

Genetics can matter in synucleinopathy, but most cases are not caused by a single inherited change. In some families, rare gene variants raise risk or affect when symptoms start, while common genetic differences may slightly influence susceptibility.

Having a genetic risk is not necessarily a diagnosis

Genetic variants are common in the general population and are a normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant tied to a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a specific gene may be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics—how genetics influence drug effects

For many living with synucleinopathy, finding the right medicine can take time, and people often wonder how genes affect treatment for synucleinopathy when the same drug helps one person more than another. Genetics is only one factor, but inherited differences can sometimes affect disease pattern and how the body handles certain medicines, which may change benefit or side effects. At the moment, most treatment choices for synucleinopathy are still based mainly on symptoms, age, other health conditions, and how someone responds over time, not on a single genetic test, and there is no routine gene-guided test that can reliably choose the best dose of levodopa or similar movement medicines. In some families with rare inherited forms, genetic results can help doctors think ahead about counseling and care, and separate pharmacogenetic tests may occasionally help if antidepressants, pain medicines, sleep medicines, or other supportive drugs cause unusual reactions. This means genetic information can sometimes add useful clues, but it is usually one part of a bigger treatment picture rather than the main decision-maker. As research grows, more personalized treatment for synucleinopathy may become possible.

There are 0 Drugs to treat Synucleinopathy
Currently no available information

Interactions with other conditions

Day to day, many living with synucleinopathy may find that other health problems change how symptoms show up and how quickly they progress. Certain diseases may overlap, meaning synucleinopathy can occur alongside Alzheimer-related brain changes or blood vessel disease in the brain, which may make memory, attention, walking, and balance problems more noticeable. Sleep disorders, especially acting out dreams during sleep, often appear early and can be an important clue when doctors are sorting out the early symptoms of synucleinopathy. Depression, anxiety, and constipation are also common, and they can affect quality of life just as much as movement or thinking changes. Infections, dehydration, or surgery may temporarily worsen confusion, stiffness, or falls, especially in older adults. For some people, blood pressure problems, bladder issues, or trouble swallowing can interact with heart disease, diabetes, or frailty, so care often works best when several conditions are treated together.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.

What other conditions can cause similar symptoms to Synucleinopathy?

Depending on which symptoms stand out, synucleinopathy can look a lot like Alzheimer’s disease and other memory disorders, other Parkinson-like conditions that cause slowness, stiffness, and balance problems, or problems such as small strokes and extra fluid around the brain that can affect walking and thinking. Medicine side effects, thyroid problems, low vitamin B12, depression, and serious sleep disorders can also cause changes in movement, memory, mood, or blood pressure that seem similar.

History

Long before doctors could study brain tissue in detail, people described illnesses marked by shaking, stiffness, slowing, memory problems, changes in sleep, and vivid hallucinations. Many living with synucleinopathy today experience a mix of these day-to-day challenges, but in the past these conditions were usually grouped by symptoms alone, so one person might be told they had Parkinson’s disease while another with a different pattern of problems received a separate label.

As medical science evolved, doctors began to notice that some of these disorders had an important feature in common. Under the microscope, researchers found abnormal clumps of a protein called α-synuclein in nerve cells and nearby brain structures. That finding helped connect conditions such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy under the broader idea of synucleinopathy.

This shift took place gradually over the 20th century. Early work focused mostly on what could be seen in clinics or at autopsy, because brain scans and modern lab tools did not yet exist. Later, improved staining methods and more careful tissue studies showed that these protein deposits were not random. They appeared in patterns that could help explain why some people mainly develop movement symptoms, while others have more trouble with thinking, behavior, blood pressure, bladder control, or sleep.

In recent decades, awareness has grown as researchers have linked these microscopic findings with symptoms that families recognize in everyday life. For many, this can mean years of constipation, acting out dreams during sleep, or a reduced sense of smell before the more obvious movement or memory changes appear. That has helped doctors better understand the early symptoms of synucleinopathy and why diagnosis can still be difficult, especially at first.

The history of synucleinopathy is also a story of changing labels. Some conditions once thought to be entirely separate are now known to overlap biologically, even if they look different from one person to the next. Researchers later identified a genetic cause in a small number of families, but most cases are not explained by a single simple factor.

Today, synucleinopathy is understood as a group of related brain disorders rather than one single illness. That broader view has improved research, made diagnosis more accurate, and helped clinicians focus not just on movement problems, but also on sleep, mood, memory, and autonomic symptoms that can affect daily life just as much.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved